Drug · DIN 02552035
COMIRNATY
PREFILLED SYRINGE
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since September 3, 2025; first marketed September 3, 2025.
- Drug Identification Number (DIN)
- 02552035
- Company (DIN owner)
- Biontech Manufacturing GmbhMainz, Rheinland-Pfalz, Germany
- Schedule
- Schedule D
- Dosage form
- Suspension
- Route
- Intramuscular
- Therapeutic class (ATC)
- COVID-19, RNA-based vaccine J07BN01
- Class
- Human
- Record last updated
- October 9, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| *SARSCOV2 S-PROTEIN MRNA, 5'[M27,3'-OGPPP(M12'-O)APG], 3'POLYA+LINKER | 30 MCG | 0.3 ML |
Other DINs named COMIRNATY
- DIN 02541823 · Marketed
- DIN 02541858 · Marketed
- DIN 02509210 · Cancelled Post Market
- DIN 02522454 · Cancelled Post Market
- DIN 02527863 · Cancelled Post Market
- DIN 02530325 · Cancelled Post Market
- DIN 02552078 · Approved